Women With Polycystic Ovary Syndrome (PCOS)
Women With Polycystic Ovary Syndrome (PCOS)
Metabolic profile in women of different body composition with polycystic ovary syndrome.
Will be performed case-control study with women with Polycystic Ovary Syndrome, according to
 the Rotterdam criteria and body mass index between 18 to 29.9. The control group will consist
 of women without Polycystic Ovary Syndrome, with a body mass index of 18 to 29.9 and no other
 comorbidities. In both groups collect anthropometric data such as age, weight, height, waist
 circumference and blood pressure. Exams will be requested: metabolic profile (total
 cholesterol (mg/dL) and fractions, triglycerides (mg/dL), blood count, liver function (U/L)
 and classical glycemic index (mg/dL); hormonal profile - insulin (uIU/ml), luteinizing
 hormone (IU/L), follicle stimulating hormone (IU/L), thyreostimulating hormone (uIU/ML),
 total and free testosterone (ng/ml), 17-hydroxyprogesterone (ng/ml), dehydroepiandrosterone
 (ng/ml), prolactin (ug/ml). Body composition (BMI) will be performed by absorption technique
 of two low energy beams emitted by X-ray - full body densitometry (DEXA). Expected result: To
 evaluate visceral fat and truncal of patients with diagnosis of Polycystic Ovary Syndrome
 without obesity.
Inclusion Criteria:

 -  Polycystic Ovary Syndrome , body mass index of 18 to 29.9, without contraceptive use.

 Exclusion Criteria:

 -  Hypothyroidism, hyperprolactinaemia (defined as serum prolactin levels greater than 25
 ng/mL)

 -  Cushing's syndrome

 -  Nonclassical congenital adrenal hyperplasia (defined as serum 17-hydroxyprogesterone
 levels greater than 1.2 and 5.2 ng/mL in the follicular and luteal phase,
 respectively) and current or previous (within the last three months) use of oral
 contraceptives and other hormonal

 -  Antidiabetic and antiobesity drugs.